Nufarm Limited (ASX:NUF) profits hit by Australian drought

The Nufarm Limited (ASX:NUF) share price could come under pressure next week after its profits were hit by the Australian drought…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Nufarm Limited (ASX: NUF) share price will be one to watch next week when it returns from a trading halt.

This morning the company released a disappointing set of results for FY 2018 and announced a $303 million pro rata renounceable entitlement offer.

Here's how Nufarm performed in FY 2018 compared to a year earlier:

  • Revenue increased 6% to $3,308 million.
  • Underlying EBITDA down 1% to $386 million.
  • Underlying net profit after tax fell 28% to $98 million.
  • Reported net loss after tax of $16 million.
  • Full year dividend down 15% to 11 cents per share.
  • $303 million pro rata renounceable entitlement offer announced.

Although a weak full year result was expected due to the negative impact of the drought in regional Australia, this result may have been even worse than feared.

According to a note out of Goldman Sachs this week, it was expecting the crop protection and specialist seeds company to post a net profit after tax of $111.4 million, down 18.1% on the prior period. Whereas its underlying result was $98 million, down 28% on FY 2017's result.

As you can see below on the EBITDA bridge, the drought (first orange column) had a major impact on its result and offset the benefits of its European acquisition and organic growth.

Source: Company presentation

Had it not been for the ANZ segment, FY 2018 would arguably have been a reasonably positive year for Nufarm.

Its North American segment saw sales and EBIT rise 10%, the Latin America segment achieved sales growth of 8% and EBIT growth of 2%, the European segment grew sales by 19% and EBIT by 1%, and the Asia segment saw sales rise 3% but EBIT fall 9%.

Outlook.

Assuming average seasonal conditions for the major selling periods in its key markets and no material impacts from government policy changes or third party supply interruptions, management expects EBITDA to be in the $500 million to $530 million range for the FY 2019 financial year.

This will be an increase of between 29.5% and 37.3% on FY 2018's result and is expected to be driven by a combination of revenue growth, the partial recovery in the Australian business, and the full year benefit of its European acquisitions.

Entitlement offer.

As well as announcing its results, the company announced a $303 million pro rata renounceable entitlement offer.

All shares offered under the offer will be issued at a price of $5.85 per share, which represents an 11.9% discount to dividend-adjusted last close price of $6.64.

The proceeds will be used to strengthen its balance sheet and help fund the continued growth of its business.

Should you invest?

Based on today's underlying result and the addition of 52 million new shares to the registry, I estimate that Nufarm's shares are changing hands at 24x underlying earnings.

I don't think that this is particularly good value for its shares and would suggest investors hold out for a better entry point.

In the meantime, I see more value in materials sector peers BHP Billiton Limited (ASX: BHP) and Rio Tinto Limited (ASX: RIO).

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

Three miners looking at a tablet.
Resources Shares

Own ASX mining shares? Experts say an upswing in commodity prices has begun

HSBC economists Paul Bloxham and Jamie Culling explain why global commodity prices are rising.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Brambles, Lifestyle Communities, Northern Star, and Select Harvests shares are sinking

These shares are having a tough session. But why?

Read more »

A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop
Share Market News

Will the Reserve Bank wait for the US Fed to cut interest rates first?

Here's when AMP thinks interest rates will be cut in the US, Australia, New Zealand, Canada and the Eurozone.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Gold bars on top of gold coins.
Gold

Is it too late to buy gold as an investment in 2024?

Can we still take advantage of gold at new record highs?

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Mergers & Acquisitions

Wesfarmers shares baulk on fresh acquisition gossip

A healthcare company gone nowhere in a decade might be on Wesfarmers' radar.

Read more »